| 000 | 01756aam a22004818i 4500 | ||
|---|---|---|---|
| 999 |
_c12867 _d12867 |
||
| 001 | 9931355903602122 | ||
| 005 | 20210304163901.0 | ||
| 008 | 930927t19941994sz a b 001 0 eng c | ||
| 010 | _a 93038330 | ||
| 020 | _a371865492X | ||
| 029 | 1 |
_aNLM _b9316220 |
|
| 035 | _a(OCoLC)29031276 | ||
| 035 | _a(WU)3135590-uwmadisondb | ||
| 035 | _a(EXLNZ-01UWI_NETWORK)999747201402121 | ||
| 040 |
_aDNLM/DLC _beng _cDLC _dNLM _dGZM _erda |
||
| 049 | _aGZZW | ||
| 050 | 0 | 0 |
_aRM301.6 _b.D78 1994 |
| 060 | 0 | 0 |
_aW1 _bDR608M v.3 1994 |
| 060 | 1 | 0 |
_aQV 38 _bD7903 1994 |
| 082 | 0 | 0 |
_a615.7 _222 _bD |
| 245 | 0 | 0 |
_aDrug absorption enhancement : _bconcepts, possibilities, limitations, and trends / _cedited by A. (Bert) G. de Boer. |
| 264 | 1 |
_aChur, Switzerland ; _aLanghorne, Pa. : _bHarwood Academic Publishers, _c[1994] |
|
| 264 | 4 | _c©1994 | |
| 300 |
_axv, 490 pages : _billustrations ; _c26 cm. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 490 | 1 |
_aDrug targeting and delivery ; _vv. 3 |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aDrugs _xBioavailability. |
|
| 650 | 0 |
_aDrugs _xPhysiological transport. |
|
| 650 | 0 |
_aProtein drugs _xBioavailability. |
|
| 650 | 0 |
_aProtein drugs _xPhysiological transport. |
|
| 650 | 0 | _aAbsorption (Physiology) | |
| 650 | 2 | 2 | _aDrug Administration Routes. |
| 650 | 1 | 2 | _aDrug Delivery Systems. |
| 650 | 2 | 2 |
_aPharmaceutical Preparations _xmetabolism. |
| 700 | 1 |
_aDe Boer, A. G. _q(Albertus G.) _eeditor |
|
| 830 | 0 |
_aDrug targeting and delivery ; _vv. 3. |
|
| 942 |
_2ddc _cBK |
||